Bioterrorism Vaccines: Liability Limits, Federalization Under Consideration
Executive Summary
The Biotechnology Industry Organization is urging Congress to limit the liability of manufacturers who enter the vaccine production business in the interest of preparedness against potential bioterrorism attacks.
You may also be interested in...
DoD Vaccine Report Proposes Interdepartmental Group To Work With Industry
The Department of Defense is recommending the development of an interdepartmental "executive council" that would advise the federal government on vaccine planning and serve as the primary point of contact with vaccine manufacturers on procurement
DoD Vaccine Report Proposes Interdepartmental Group To Work With Industry
The Department of Defense is recommending the development of an interdepartmental "executive council" that would advise the federal government on vaccine planning and serve as the primary point of contact with vaccine manufacturers on procurement
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply